CARD11 and diffuse large B-cell lymphoma: In particular, MYD88, CARD11, EBF1, IRF4, and IKBKB inactivation induced the death of ABC DLBCL cells, confirming that these oncogenes affect cell survival and might represent ideal targets for future tailored therapies [19].